The overall results demonstrated that SUMO1P3 is a highly specific biomarker for bladder cancer in non-invasive liquid biopsy analysis and can discriminate low-grade from high-grade NMIBC and MIBC, which represent aggressive and invasive phenotypes of the tumor. This evidence concerns the gene SUMO1P3 and neoplasm.